SALVAGE THERAPY IN RECURRENT GERM-CELL CANCER - IFOSFAMIDE AND CISPLATIN PLUS EITHER VINBLASTINE OR ETOPOSIDE

被引：232

作者：

LOEHRER, PJ ^{[1
]}

LAUER, R ^{[1
]}

ROTH, BJ ^{[1
]}

WILLIAMS, SD ^{[1
]}

KALASINSKI, LA ^{[1
]}

EINHORN, LH ^{[1
]}

机构：

[1] INDIANA UNIV, SCH MED, INDIANAPOLIS, IN 46202 USA

来源：

关键词：

D O I：

10.7326/0003-4819-109-7-540

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：540 / 546

页数：7

共 30 条

[1] AIGINGER P, 1982, 13TH P INT CANC C SE, V13, P180
[2] ROLE OF ETOPOSIDE-BASED CHEMOTHERAPY IN THE TREATMENT OF PATIENTS WITH REFRACTORY OR RELAPSING GERM-CELL TUMORS
BOSL, GJ
YAGODA, A
GOLBEY, RB
WHITMORE, W
HERR, H
SOGANI, P
MORSE, M
VOGELZANG, N
MACDONALD, G
[J]. AMERICAN JOURNAL OF MEDICINE, 1985, 78 (03) : 423 - 428
[3] BOUTIS LL, 1982, 13TH P INT CANC C SE, V13, P181
[4] CYCLOPHOSPHAMIDE VERSUS IFOSFAMIDE - FINAL REPORT OF A RANDOMIZED PHASE-II TRIAL IN ADULT SOFT-TISSUE SARCOMAS
BRAMWELL, VHC
MOURIDSEN, HT
SANTORO, A
BLACKLEDGE, G
SOMERS, R
VERWEY, J
DOMBERNOWSKY, P
ONSRUD, M
THOMAS, D
SYLVESTER, R
VANOOSTEROM, A
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (03): : 311 - 321
[5] BRESLOW NE, 1980, IARC SCI PUBL, V32, P192
[6] THE OXAZAPHOSPHORINES
BROCK, N
[J]. CANCER TREATMENT REVIEWS, 1983, 10 : 3 - 15
[7] PHARMACOKINETICS AND MECHANISM OF ACTION OF DETOXIFYING LOW-MOLECULAR-WEIGHT THIOLS
BROCK, N
HILGARD, P
POHL, J
ORMSTAD, K
ORRENIUS, S
[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1984, 108 (01) : 87 - 97
[8] A CONFIDENCE-INTERVAL FOR THE MEDIAN SURVIVAL-TIME
BROOKMEYER, R
CROWLEY, J
[J]. BIOMETRICS, 1982, 38 (01) : 29 - 41
[9] BUCKNER CD, 1974, CANCER CHEMOTH REP 1, V58, P709
[10] COHEN MH, 1975, CANCER CHEMOTH REP 1, V59, P751